Selecting and Pre-Setting Amplification for Children: Where Do We Begin?

Trimming the fat, do we know where to begin?

T he worldwide prevalence of obese and overweight individuals has increased ≈3-fold during the past 30 years, from 857 million in 1980 to 2.1 billion in 2014. 1 Once thought to be a rich world problem, rates have increased dramatically even in low-and middle-income countries with 1 in 7 obese individuals residing in China and India. As global demographic trends continue to shift toward urbaniza...

Clinical Pharmacy in Iran: Where Do We Stand?

Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...

Clinical Pharmacy in Iran: Where Do We Stand?

Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...

Adhesive small bowel obstruction: where do we stand now?

Adhesive small bowel obstruction (ASBO) is one of the most frequently encountered disorders in Emergency Surgery Departments worldwide without negligible hospital admission rates and social costs (1,2). Notwithstanding significant improvements in techniques and materials, intra-abdominal adhesions following abdominal surgery still represent a major unsolved and debated issue harbouring challeng...

The Battle Against COVID-19: Where Do We Stand Now?